Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
5,427,848
-
Share change
-
-696,635
-
Total reported value
-
$37,720,040
-
Put/Call ratio
-
37%
-
Price per share
-
$6.95
-
Number of holders
-
47
-
Value change
-
+$227,967
-
Number of buys
-
16
-
Number of sells
-
24
Institutional Holders of MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK) as of Q1 2019
As of 31 Mar 2019,
MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,427,848 shares.
The largest 10 holders included
Newtyn Management, LLC, 22NW, LP, DIMENSIONAL FUND ADVISORS LP, Western Standard LLC, TIAA CREF INVESTMENT MANAGEMENT LLC, BlackRock Inc., VANGUARD GROUP INC, WITTENBERG INVESTMENT MANAGEMENT, INC., Connor, Clark & Lunn Investment Management Ltd., and D. E. Shaw & Co., Inc..
This page lists
47
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.